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Decreased Intraocular Pressure
Induced by Nitric Oxide Donors Is
Correlated to Nitrite Production in the
Rabbit Eye
Francine F. Behar-Cohen,* Olivier Goureau,*
Frangois D'Hermies,^ and Yves Courtois*
Purpose. To evaluate the effect of intraocular adminis-
tration of nitric oxide (NO) donors in the rabbit eye on
intraocular pressure (IOP), inflammation, and toxicity.
Methods. Intravitreal and intracameral injections of two
NO donors, SIN-1 and SNAP, and SIN-1C and BSS were
performed. Clinical examination, IOP measurements,
protein evaluation in aqueous humor, and histologic
analysis of the ocular globes were realized. Nitric oxide
release was demonstrated by nitrite production in the
aqueous humor and in the vitreous using the Griess
reaction.
Results. The drastic decrease of IOP, observed after a
single NO donor injection, was correlated direcdy with
nitrite production and, thus, to NO release. Injection
of inactive metabolite of SIN-1, SIN-1 C, which is not
able to release NO, did not modulate IOP. When ad-
ministered in the aqueous humor or in the vitreous,
NO did not diffuse from one segment of die eye to
another. No inflammation or histologic damage was
observed as a result of a single NO donor administra-
tion.
Conclusions. Nitric oxide is implicated direcdy in the
regulation of IOP and its acute, and massive release
into the rabbit eye did not induce inflammation or
other growth toxic effects on the ocular tissues. Invest
Ophthalmol Vis Sci. 1996;37:1711-1715.
vjrlaucoma seems to be a multifactorial condition
with field loss that may lead to blindness. It is unclear
whether the primary event is neurogenic or vascular or
is the result of abnormal regulation of the intraocular
pressure (IOP). However, IOP consistently has been
found to be one of the most important risk factors in
glaucomatous injury, and it has been demonstrated
that lowering the IOP would be protective.1 2 The role
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of nitrovasodilators was suspected because their sys-
temic administration induces a decrease of the intra-
ocular pressure without altering systemic blood pres-
sure.3 More recently, Nathanson demonstrated that
topical administration of nitrovasodilators lowers IOP4
and that this change was caused by the decrease of
the resistance of the aqueous humor leaving the eye
and not to a reduction of aqueous humor production.'
The effects of these compounds, identified as nitric
oxide (NO) donors, suggest the role of NO in the
regulation of IOP. The enzyme responsible for NO
formation, the NO synthase (NOS), has been identi-
fied in the rat eye. It was found essentially in periph-
eral ocular nerve fibers arising from parasympathetic
ganglia.1' A recent report demonstrated that in hu-
mans, another isoform of NOS is expressed in
Schlemm's canal, in the trabecular meshwork, and in
the ciliary muscle.7 On the other hand, topical applica-
tion of nitroglycerin has an inconsistent effect on IOP.
The nitroglycerin-induced IOP decrease in monkeys
obtained by Schuman et al5 in normal eyes, has not
been reproduced either in normal glaucoma or in a
model of laser-induced glaucoma.8 However, the
pathogenesis of the laser glaucoma model might be
different from open angle glaucoma in humans, which
explains the lack of efficiency of nitroglycerin. Be-
cause the effect of NO donors is controversial, we
investigated the effect on IOP of two NO donors ad-
ministered by injection into the ocular media and the
subsequent release of nitrite, which reflects NO pro-
duction. The potential inflammatory and toxic effects
of these compounds were evaluated by protein infil-
tration and histologic analysis.
MATERIAL AND METHODS. Animals. The
rabbits used in this study, Fauve de Bourgogne pig-
mented females (weight range, 2.5 to 3 kg; age range,
10 to 12 weeks) were cared for and treated in accor-
dance with the ARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Research. Only one
eye was treated for each animal.
Reagents. Sydnonimide analogs, 3 morpholino-
sydnonimide (SIN-1), N-morpholinoimuno-acetoni-
trosyle (SIN-1 C), and S-nitrosoacetylpenillamine (SNAP),
were obtained from TEBU (Biomol Research Labora-
tories, Plymouth, MA). Balanced saline solution (BSS)
was obtained from Alcon (Rueil-Malmaison, France).
Reagents were diluted in the BSS solvent and injected
as soon as dissolved.
Measure of Intraocular Pressure. Rabbits were
housed under standard conditions at least 8 days before
the experiments. They were exposed to natural illumina-
tion. Experiments were scheduled for die same time
each day, from 9 AM until 6 PM, and were performed
1712 Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
during winter. Intraocular pressure was determined by
using both Schiotz and Goldmann tonometer (Haag-
Sreit, Bern, Switzerland). Before each set of measures,
one drop of oxybuprocaine chlorydrate 0.4% (Novesine,
Chibret, France) was instilled three times every 10 min-
utes. Five measures of IOP were performed to accustom
the rabbit to the procedure before experiments were
begun. At each time, the mean of three measures was
calculated for the Schiotz and the Goldmann measures.
Finally, the mean of these measures was calculated.
Intraocular Injections. Nitric oxide donors were ad-
ministrated by direct intraocular injections into the vitre-
ous (V) or the aqueous humor (AH) using a Hamilton
syringe (Poly-Labo, Paris, France) and 30 g needles
(Microlance 3, Becton Dickinson, Spain). Intravitreous
injections were performed through the sclera, 3 mm
from the limbus in the temporal and superior quadrant.
Intracameral injections were performed through the
cornea 2 mm from the limbus to avoid limbus vessels.
Fifty microliters was injected to reduce IOP variations
from injections.
Nitrite Evaluation. Aqueous humor was obtained by
anterior chamber puncture (1 ml syringe and 30 g nee-
dle) . Vitreous samples were obtained from an anterior
vitrectomy. After the last IOP measurement, animals
were sedated with 2 mg/kg nidazolam (Hypnovel;
Roche, Neuilly-sur-Seine, France) given intramuscularly
and were anesthetized with 60 mg/kg intramuscular ket-
amine (Ketalar, Parke-Davis, Courbevoie, France). First
an extracapsular extraction of the lens was performed,
then the posterior capsule and the posterior hyaloid
membranes were dissected to perform the vitrectomy.
This technique was used to prevent any bleeding be-
cause of a two-port vitrectomy, which can interfere with
nitrite dosage. Fifty microliters of AH or V were assayed
in triplicate using the spectrophotometric method based
on the Griess reaction, as previously described.9
Clinical Evaluation. Animals were examined using
a Haag-Steit 900 (Bern, Switzerland) biomicroscope be-
fore injection, after injection, and before every IOP mea-
surement, and then were photographed. Anterior and
posterior segments of the eye were examined as well as
the retina by using a 90 D Volk II lens.
Protein Evaluation. Protein was assayed in AH sam-
ples according to the method of Bradford (Bio Rad
kit, Les Ulis, France). For the quantification of protein,
bovine serum albumin was used as a standard. Aqueous
humor samples were obtained by anterior puncture 1
or 4 hours after SIN-1 or SNAP injection.
Histologic Analysis. Animals were killed with lethal
doses of intramuscular pentobarbital (Nembutal; Abbot,
Saint-Remy sur Avre, France), light microscopy analysis
of ocular globes was performed 1 hour, 24 hours, 15
days, and 30 days after NO donor treatment.
Statistical Analysis. Results are expressed as means
± standard deviation and were analyzed by the nonpara-
metric Mann-Whitney test. P < 0.05 was considered
significant.
RESULTS. Intraocular Pressure Decrease. The
basal IOP in pigmented Fauve de Bourgogne rabbits
was 21 ± 3.5 mm Hg measured by Schiotz tonometer
and 23 ± 2 mm Hg measured by Goldmann tonome-
ter (unpaired Mest, P = 0.08, n = 8), which is slightly
higher than the IOP reported by others on New
Zealand White rabbits.10 Intravitreous injection of 50
fA SIN-1 (20 mM) induced a transitory increase of
IOP just after injection (33% ± 3%), which also was
observed with SIN-1 C and BSS (Fig. 1). This increase
was caused by the injected volume in the vitreous cav-
ity and was not the result of a specific action of NO
donors. Normal values of IOP were observed approxi-
mately 30 minutes after the injection. In SIN-l-in-
jected eyes, a mean decrease in IOP of 71% ± 5% was
observed 60 minutes after injection. Normal values
were recovered approximately 3 hours later (Fig. 1).
No effect on IOP was observed as a result of intravi-
treous injection of the inactive metabolite of SIN-1,
SIN-lC",orBSS (Fig. 1).
The intracameral injection of 50 fA SIN-1 (20
mM) initially induced a 44% ± 6% (n = 4) decrease
in the basal IOP resulting from the intracameral punc-
ture because the same lowering was observed in the
BSS-injected group (49% ± 4%, n = 4). Figure 2 shows
in the SIN-1-treated group, but not in the BSS-treated
group, a decrease of 68% ± 8% (n = 6) in IOP approx-
imately 1 hour after injection. Normal IOP was recov-
ered approximately 3 hours after injection. This
change in the IOP was not observed in the BSS-in-
jected group nor in the SIN-1 C-treated group (Fig. 2).




FIGURE 1. Measurements of IOP after intravitreous injection of
50 A*1 SIN-1 and SIN-1C (20 mM). Values are means ± SD.
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FIGURE 2. Measurement of intraocular pressure after intra-
cameral injection of 50 fx\ SIN-1 and SIN-1C (20 mM). Val-
ues are means ± SD.
mM) initially induced an increase of 30% in the IOP
caused by the volume injected into the vitreous cavity
(Fig. 3A). As described above, this variation in IOP
also was observed in the control BSS-injected eyes and
was not caused by NO donors. The normal IOP re-
curred after 15 to 30 minutes (23 ± 8 minutes), fol-
lowed by a dramatic decrease of 72% in the IOP was
measured 90 minutes after SNAP injection. Normal
values were recovered approximately 6 hours after in-
jection (Fig. 3A). In experiments not reported herein,
intracameral injection of SNAP induced changes in
IOP similar to those observed with SIN-1, except that
IOP decrease lasted 6 hours with the latter.
Evaluation of Nitrite Production in Aqueous Hu-
mor and Vitreous. When SNAP was injected into the
vitreous, nitrite production was augmented markedly
in the V after 30 minutes and lasted 6 hours after
injection (Figs. 3B, 4A). The time course and amount




FIGURE 3. Correlation between intraocular pressure and ni-
trite production after intravitreous injection of SNAP. After
injection of 50 ^1 SNAP (20 mM), the intraocular pressure
was measured 15, 30, and 60 minutes and every hour until
return to normal values. At each time point, four rabbits
underwent vitrectomy to sample the vitreous and were,
therefore, excluded from the time course of intraocular





FIGURE 4. Evaluation of nitrites in aqueous humor and vitreous
after either intravitreous (A) or intracameral (B) administra-
tion of 50 fA SNAP (20 mM). At each time point, aqueous
humor was first sampled before performing an anterior vitrec-
tomy to sample the vitreous. Values are given as means ± SD.
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ering (Fig. 3). No nitrite increase was detected in the
AH after intravitreal injection of SNAP (Fig. 4A). Iden-
tical correlations have been obtained with intravitreal
injection of SIN-1 (data not shown). SIN-1C, which is
unable to release NO, did not produce nitrite in the
V 1 hour after injection (3.1 ± 2.7 //M, n = 4).
After intracameral injection of SNAP, a maximal
amount of nitrite was detected in the AH after 30
minutes and slowly decreased to the control values
within 4 hours (Fig. 4B). No nitrites were detected in
the V after intracameral injection of SNAP, suggesting
that NO donor administration in either the anterior
or the posterior segment of the eye did not diffuse
from one segment to the other.
Protein Evaluation. The protein concentration in
AH, 1 hour and 4 hours after 50 (j,\ SIN-1 (20 mM)
intravitreous injection, were, respectively, 0.4 ± 0.21
and 0.45 ± 0.24 mg/ml (n = 4), compared, respec-
tively, to 0.42 ± 0.09 and 0.43 ± 0.25 mg/ml (n = 4)
in the BSS-injected group (P = 0.7, P = 0.68). In the
group of rabbits injected with 50 fA SNAP (20 mM),
the protein concentration in AH were 0.55 ± 0.04
and 0.36 ± 0.4 mg/ml (P = 0.29, P = 0.28; n = 4),
respectively, at 1 hour and 4 hours after the injection.
No statistical difference in the concentration of pro-
tein in the group of rabbits injected with NO donors,
compared to the group of rabbits injected with BSS,
was observed.
Histologic Analysis. Histologic analysis of the eyes
1 hour, 24 hours, 15 days, and 30 days after treatment
showed no lesions in the corneal endothelium, the
iris, or the ciliary body, and no damage in the retina.
No signs of inflammation, such as cell infiltration, was
observed, and no cell suffering or death were detected
as a consequence of the administration of the high
concentrations of NO donors (data not shown).
DISCUSSION. Direct injections of NO donors
into the ocular globe induced a drastic lowering of the
IOP, more marked compared to topical application of
these compounds.4 We demonstrate, for the first time,
that there is a direct production of NO in the ocular
media by nitrite evaluation in the AH and in the V
after NO donor injection and that the IOP decrease
is correlated to NO production. A similar time-course
of SIN-1-induced IOP decrease was obtained when the
NO donor was injected into the V or into the AH. The
NO produced either in the AH or in the V might reach
the ciliary muscle directly to interact with guanylate
cyclase, leading to a cyclic guanosine monophosphate
increase, responsible for the IOP modulation.412 Fur-
thermore, injection of the inactive product, SIN-1 C,
did not release NO and then did not decrease IOP,
confirming the direct role of NO on the regulation
of IOP. In agreement with our data, topical applica-
tion of the inactive precursor of SIN-1, molsidomine,
failed to decrease IOP in the rabbit.4 SNAP action on
IOP lasted longer than SIN-1 after either intravitreal
or intracameral injection, probably because of the dif-
ferential kinetics of NO release by the two compounds.
Nitric oxide donors and the NO released do not seem
to diffuse from V to AH and from AH to V because no
increase in nitrite is observed in AH after intravitreal
injection nor in V after intracameral injection. High
concentrations of thiols located in the lens might act
as scavengers for NO and serve as a barrier to the
diffusion of NO from one segment of the eye to the
other. Moreover, diffusion from the AH into the V or
to the V into the anterior aqueous might be diverted
by the increased outflow induced by NO donors.4'5 As
a result of high concentrated NO solutions in the
globe, a transitory vasodilation of conjunctival and
episcleral vessels was observed that lasted approxi-
mately 20 minutes. No flare in the AH or in the V
and no exudation of protein or cell infiltration were
observed after NO administration, as demonstrated by
protein concentration in AH and histologic analysis
of whole ocular globes. These results suggest that a
single injection of NO donors failed to induce a break-
down of the blood-aqueous barrier, even at the maxi-
mal decrease of IOP. Thus, no relation might be estab-
lished between IOP changes and a breakdown of the
blood-aqueous barrier. Furthermore, the observation
of the lenses 1 month after acute production of NO
in the vitreous did not show any cataractogenic effect
of these compounds. Recent studies have demon-
strated that NO can be involved in experimentally
induced inflammatory responses, such as endotoxin-
induced uveitis, which could partially be inhibited by
intraperitoneal administration of a NOS inhibitor.9
However, acute excessive NO might not induce in-
flammation directly or cause tissue damage, as shown
by our histologic analysis of ocular globe at different
times after one NO donor injection. The implication
of NO in the inflammatory response or in retinal toxic-
ity could result either from chronic effects of NO or
from a combination with other free radicals or cyto-
kines produced during the inflammatory process.
In conclusion, these experiments demonstrated
the direct correlation between intraocular NO pro-
duction and IOP lowering and the absence of a toxic
effect by the massive administration of NO donors.
Currently, we are investigating whether chronic ad-
ministration of NO could lead to tissue damage or
inflammation.
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